These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33354763)

  • 1. Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-β-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.
    Zarate SM; Pandey G; Chilukuri S; Garcia JA; Cude B; Storey S; Salem NA; Bancroft EA; Hook M; Srinivasan R
    J Neurochem; 2021 May; 157(3):710-726. PubMed ID: 33354763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
    Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
    Abin-Carriquiry JA; Costa G; Urbanavicius J; Cassels BK; Rebolledo-Fuentes M; Wonnacott S; Dajas F
    Eur J Pharmacol; 2008 Jul; 589(1-3):80-4. PubMed ID: 18589414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease.
    Farzam SA; Darabi S; Haghdoost-Yazdi H; Zaferani Y
    Neurol Res; 2024 Aug; 46(8):763-771. PubMed ID: 38740025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
    Fletcher EJR; Moon LDF; Duty S
    BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress.
    Tao K; Wang B; Feng D; Zhang W; Lu F; Lai J; Huang L; Nie T; Yang Q
    Neurosci Bull; 2016 Feb; 32(1):61-9. PubMed ID: 26762342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Antunes MS; Ladd FVL; Ladd AABL; Moreira AL; Boeira SP; Cattelan Souza L
    Metab Brain Dis; 2021 Jan; 36(1):153-167. PubMed ID: 33057922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
    Wu L; Tian YY; Shi JP; Xie W; Shi JQ; Lu J; Zhang YD
    Neurosci Lett; 2013 Aug; 548():50-5. PubMed ID: 23774475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M; Date I; Tomita S; Ohmoto T
    Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways.
    Yang X; Li Y; Chen L; Xu M; Wu J; Zhang P; Nel D; Sun B
    Pharm Biol; 2020 Dec; 58(1):686-694. PubMed ID: 32658590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
    Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
    Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
    Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.